[2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate

C37H42F3NO4 — CID 20728031

IUPAC[2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
SMILESCC(=O)OCC(=O)[C@]1(C#CC(F)(F)F)CC[C@H]2[C@@H]3CC(C)C4=CC(=O)CCC4=C3[C@@H](c3ccc(N4CCCCC4)cc3)C[C@@]21C
InChIInChI=1S/C37H42F3NO4/c1-23-19-30-32-13-14-36(15-16-37(38,39)40,33(44)22-45-24(2)42)35(32,3)21-31(34(30)28-12-11-27(43)20-29(23)28)25-7-9-26(10-8-25)41-17-5-4-6-18-41/h7-10,20,23,30-32H,4-6,11-14,17-19,21-22H2,1-3H3/t23?,30-,31+,32-,35-,36+/m0/s1
InChIKeyXHTBYNANCNCDDY-PDYCKLJDSA-N
MW621.74 g/mol
LogP7.51
Rot. Bonds5

About [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate

[2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate (PubChem CID 20728031) has the molecular formula C37H42F3NO4 and a molecular weight of 621.74 g/mol. Its IUPAC name is [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate.

Molecular Properties

Compound Name[2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
PubChem CID20728031
Molecular FormulaC37H42F3NO4
Molecular Weight621.74 g/mol
Exact Mass621.31
IUPAC Name[2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
SMILESCC(=O)OCC(=O)[C@]1(C#CC(F)(F)F)CC[C@H]2[C@@H]3CC(C)C4=CC(=O)CCC4=C3[C@@H](c3ccc(N4CCCCC4)cc3)C[C@@]21C
InChIInChI=1S/C37H42F3NO4/c1-23-19-30-32-13-14-36(15-16-37(38,39)40,33(44)22-45-24(2)42)35(32,3)21-31(34(30)28-12-11-27(43)20-29(23)28)25-7-9-26(10-8-25)41-17-5-4-6-18-41/h7-10,20,23,30-32H,4-6,11-14,17-19,21-22H2,1-3H3/t23?,30-,31+,32-,35-,36+/m0/s1
InChIKeyXHTBYNANCNCDDY-PDYCKLJDSA-N
XLogP7.51
TPSA63.68 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500621.74
LogP ≤ 57.51
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate?
The IUPAC name of [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate (CID 20728031) is [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate.
What is the SMILES notation for [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate?
The canonical SMILES for [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate is CC(=O)OCC(=O)[C@]1(C#CC(F)(F)F)CC[C@H]2[C@@H]3CC(C)C4=CC(=O)CCC4=C3[C@@H](c3ccc(N4CCCCC4)cc3)C[C@@]21C.
What is the InChIKey of [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate?
The InChIKey is XHTBYNANCNCDDY-PDYCKLJDSA-N. The full InChI is InChI=1S/C37H42F3NO4/c1-23-19-30-32-13-14-36(15-16-37(38,39)40,33(44)22-45-24(2)42)35(32,3)21-31(34(30)28-12-11-27(43)20-29(23)28)25-7-9-26(10-8-25)41-17-5-4-6-18-41/h7-10,20,23,30-32H,4-6,11-14,17-19,21-22H2,1-3H3/t23?,30-,31+,32-,35-,36+/m0/s1.
What are the key properties of [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate?
[2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate has a molecular weight of 621.74 g/mol, XLogP of 7.51, 5 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[(8S,11R,13S,14S,17R)-6,13-dimethyl-3-oxo-11-(4-piperidin-1-ylphenyl)-17-(3,3,3-trifluoroprop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate is sourced from PubChem (CID 20728031), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).